Join us as we welcome Despina Vasiliou, Innovaderm's Regulatory Affairs Manager. In this episode, Despina shares her insights from the Regulatory Affairs Professionals Society (RAPS) Convergence 2024, held in Long Beach. Topics include the impact of artificial intelligence, addressing unmet medical needs, regulatory conversations, solution circles, and valuable networking opportunities. Tune in for a deep dive into the latest trends and discussions shaping the regulatory landscape.

We are thrilled to have Nadine Clervoix, Clinical Research Coordinator at Innovaderm, with 25 years of experience in clinical research. In this episode, we explore the impact of seasonality on dermatology clinical trial patients, covering 4 main points: effects on skin, lifestyle restrictions, study design, and patient retention. Join us as we explore how seasonal changes influence patient symptoms, treatment efficacy, and recruitment in clinical trials. Discover insights on managing these challenges and optimizing trial outcomes through strategic adjustments and innovative approaches, ensuring effective and efficient dermatology research throughout the year.

Join us as we speak with France Wagner, Senior Director of Operational Strategy at Innovaderm, in our latest podcast episode. With over 15 years of experience in the CRO industry, France shares her insights on the complexities of efficacy assessments, focusing on data capture of clinical outcome assessments (COAs), the debate between paper and electronic methods, and measuring compliance for patient-reported outcomes (PROs) at home. Do not miss this enlightening discussion. Listen now.

Join us on Phase Forward as Éric Hardy, Senior Director in Biometrics at Innovaderm, dives into the critical role of system integration in clinical trials. With 27 years of experience, Éric discusses the significance, benefits, and challenges of integrating various platforms to streamline data management and enhance trial efficiency. Do not miss this insightful episode.

Join us for a special episode, live from the 2024 EADV in Amsterdam. We welcome Pedro Rosés Diaz de Rada, Director of Project Management at Innovaderm, who brings over 20 years of experience in the pharmaceutical and CRO environment. Pedro is renowned for his leadership and expertise in global clinical trial management, complex portfolio delivery, and achieving project objectives. This episodes explores the power of patient recruitment, highlighting patient-centric approaches, and the latest innovations in the field.

Join us on Phase Forward as we welcome Janet Overvelde, Senior Director of Project Management at Innovaderm Research, a vanguard in clinical research productivity. Dive into an insightful discussion on the role of rater training in clinical trials and its profound impact on the integrity and success of research outcomes. Do not miss this deep dive into a topic that shapes the efficacy and future of clinical studies. Tune in to enrich your understanding and stay ahead in the field of clinical research.

We are thrilled to host Kyle Given, Innovaderm's VP of Clinical Operations. With a wealth of 20 years of industry experience, Kyle has honed his expertise in clinical operations, central data monitoring, clinical trial management, and clinical systems. He brings this wealth of knowledge to our discussion on the role of clinical research associates (CRA) in clinical projects. Join us as we explore the evolving skill set of CRAs, underscore the importance of specialized training, and unravel the intricate dynamics of CRA-site relationships.

In this enlightening episode, we are joined by Dr. Jasmina Jankicevic, the Chief Medical Officer of Innovaderm. Dr. Jankicevic is a globally recognized authority in the field of dermatology drug development, with her extensive experience spanning clinical trials and regulatory approvals. In this episode, we dive into the world of gene therapy. We will explore how gene therapy could revolutionize the field of dermatology, discuss the impact of stem cell therapy on dermatological treatments, and address the critical challenges that need to be considered when investigating gene therapy.

We are joined by Jason Shuris, Chief Business Officer at Innovaderm. With 25 years of experience in healthcare and life sciences, Jason shares his insights on the advantages of niche CROs. The episode covers his deep scientific knowledge, strategic trial expertise, and understanding of disease-related endpoints. Tune in for this enlightening conversation!

Welcome to our enlightening podcast episode featuring Mounia Lahjou, a seasoned project director at Innovaderm. Leveraging her extensive experience in the pharmaceutical industry, we will dive into the insights gained from Phase 3 clinical trials. We will explore the importance of comprehensive documentation, adherence to process compliance, and the pursuit of process improvement. Join us as we navigate trial management complexities, learning from Mounia’s insights to enhance your team and company’s performance. Tune in for this enriching experience.